HopeStage
Back to all studies
UnknownNCT04763655

Neural Biomarkers of Electroconvulsive Therapy Response

Study assessmentsAges 18–80United StatesSchizophrenia
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 80 years.

Listed locations
Glen OaksSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: April 1, 2020
Recruitment status
Unknown
Enrollment listed in the registry
75
Sponsor
Northwell Health
Sponsor type
Unknown or unclear
Study type
Diagnostic Test
Intervention type
Diagnostic test
Locations
United States
Age range
From 18 Years to 80 Years
Official registry ID
NCT04763655
Official title
Show the full official title

Neural Biomarkers of Electroconvulsive Therapy Response in Schizophrenia

Recruitment & locations

Status unknown

Glen Oaks

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Northwell Health.

Who can participate?

Listed age limits: 18 years to 80 years.

Want to explore more studies?

Explore studies